N. Sarita Shah

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 13 papers. Top paper: “TCA cycle remodeling drives proinflammatory signaling in humans with pulmonary tuberculosis”.

TCA cycle remodeling drives proinflammatory signaling in humans with pulmonary tuberculosis

PLoS Pathogens(2021)10.1371/journal.ppat.1009941

N/A

0DataRank · unranked

52 citations

Dean P. Jones, Ashish Sharma, Manoj Khadka, Ken Liu, Russell R. Kempker +11 more

Drug susceptibility patterns of Mycobacterium tuberculosis from adults with multidrug-resistant tuberculosis and implications for a household contact preventive therapy trial

BMC Infectious Diseases(2021)10.1186/s12879-021-05884-4

N/A

0DataRank · unranked

11 citations

Anne‐Marie Demers, Soyeon Kim, Sara McCallum, Kathleen D. Eisenach, Michael D. Hughes +14 more

TCA cycle remodeling drives proinflammatory signaling in humans with pulmonary tuberculosis

medRxiv(2021)10.1101/2021.01.23.21250380

N/A

0DataRank · unranked

3 citations

Dean P. Jones, A. Sharma, Manoj Khadka, Ken Liu, Russell R. Kempker +11 more

Nucleocapsid Antigenemia Is a Marker of Acute SARS-CoV-2 Infection

The Journal of Infectious Diseases(2022)10.1093/infdis/jiac225

N/A

0DataRank · unranked

22 citations

Gregory L. Damhorst, Daniel S. Graciaa, Kaleb McLendon, William O’Sick, Chad Robichaux +17 more

Estimating severe acute respiratory coronavirus virus 2 (SARS-CoV-2) seroprevalence from residual clinical blood samples, January–March 2021

Antimicrobial Stewardship & Healthcare Epidemiology(2022)10.1017/ash.2022.298

N/A

0DataRank · unranked

2 citations

Hans Verkerke, Jeannette Guarner, Ana Maria Moldoveanu, Narayanaiah Cheedarla, Connie M. Arthur +8 more

Factors associated with prevalent Mycobacterium tuberculosis infection and disease among adolescents and adults exposed to rifampin-resistant tuberculosis in the household

PLoS ONE(2023)10.1371/journal.pone.0283290

N/A

0DataRank · unranked

2 citations

Anneke C. Hesseling, Xingye Wu, Michael D. Hughes, N. Sarita Shah, Sanjay Gaikwad +22 more

The impact of COVID-19 national lockdowns on drug-resistant tuberculosis in KwaZulu-Natal, South Africa: A spatial analysis

Annals of Epidemiology(2024)10.1016/j.annepidem.2024.07.044

N/A

0DataRank · unranked

3 citations

Neel R. Gandhi, N. Sarita Shah, Kogieleum Naidoo, Sara C. Auld, Jason R. Andrews +9 more

Effectiveness of Double-Dose Dolutegravir in People Receiving Rifampin-based Tuberculosis Treatment: An Observational, Cohort Study of People With HIV From 6 Countries

Clinical Infectious Diseases(2024)10.1093/cid/ciae269

N/A

0DataRank · unranked

4 citations

Cissy Kityo, Michael D. Hughes, Caitlyn McCarthy, Carole L. Wallis, Mina C. Hosseinipour +28 more

A Plasma Metabolic Signature to Diagnose Pulmonary Tuberculosis and Monitor Treatment Response

The Journal of Infectious Diseases(2025)10.1093/infdis/jiaf240

N/A

0DataRank · unranked

9 citations

Kidist Bobosha, Naythra Narayanan, Neel Gandhi, Cheryl L. Day, Jyothi Rengarajan +83 more

Virological and drug-resistance outcomes for people living with HIV initiating or switching to tenofovir, lamivudine, and dolutegravir in six PEPFAR-supported countries: a prospective cohort study

The Lancet HIV(2025)10.1016/s2352-3018(25)00162-6

N/A

0DataRank · unranked

3 citations

Caitlyn McCarthy, Carole L. Wallis, Cissy Kityo, Michael D. Hughes, Catherine Godfrey +44 more

Preventing Multidrug-Resistant Tuberculosis: The Dawn of a New Era

Clinical Infectious Diseases(2025)10.1093/cid/ciaf426

N/A

0DataRank · unranked

1 citations

Susan Swindells, Amita Gupta, N. Sarita Shah, Michael D. Hughes, Soyeon Kim +5 more

Virology Outcomes of Tenofovir-lamivudine-dolutegravir in Treatment-naïve and Virologically Suppressed Individuals Switching From an NNRTI-based Regimen: An Observational Analysis at 13 Sites

Open Forum Infectious Diseases(2025)10.1093/ofid/ofaf270

N/A

0DataRank · unranked

1 citations

Caitlyn McCarthy, Serena P. Koenig, Michael D Hughes, Carole L. Wallis, Isaac Tsikhutsu +41 more

Protecting households on exposure to newly diagnosed index multidrug-resistant tuberculosis patients: Study protocol for the PHOENIx phase 3 clinical trial

Contemporary Clinical Trials(2025)10.1016/j.cct.2025.108084

N/A

0DataRank · unranked

0 citations

Michael D. Hughes, Soyeon Kim, Lisa Aaron, Linda Naini, Nishi Suryavanshi +14 more